Measurable weight loss typically becomes evident by weeks 5 through 8 as the dose increases to 4mg
PubMed Gerstein HC, Bosch J, Dagenais GR, et al
An average of 7.9 3.8 kg of weight was lost as a result of liraglutide medication, which also markedly improved general health and sexual performance
Emerging preclinical research suggests that GLP-1 receptor agonists may directly inhibit the proliferation of neoplastic cells, promote programmed cell death (apoptosis), and reduce metastatic potential through the regulation of matrix metalloproteinases and their inhibitors
For those comparing these medications, our comprehensive comparison guide covers the differences in mechanism, efficacy, and side effect profiles across all three
PMCID: PMC5990155 ) Prez E, Martnez-Tadeo J, Callero A, Hernndez G, Rodrguez-Plata E, Garca-Robaina JC (2014) A case report of allergy to exenatide